VitaNova Life Sciences Reports 14% Revenue Growth but Faces Net Loss in Fiscal Year Ending April 30, 2026

VitaNova Life Sciences Corporation, formerly known as Yijia Group Corp., reported a revenue increase of 14% for the fiscal year ending April 30, 2026, generating $3.03 million compared to $2.66 million in the previous year. This growth was primarily driven by the introduction of a new line of healthy food products, which contributed $1.06 million to total revenues. However, the company experienced a net loss of $37,304, a significant decline from the net income of $850,746 reported in the prior fiscal year. The gross profit margin also decreased from 59% to 30%, attributed to lower margins on the new food products compared to traditional dietary supplements.

The company underwent several strategic changes during the fiscal year, including the establishment of two wholly-owned subsidiaries: NutriPeak Trading Corporation, focused on dietary supplements, and VitaNova Global Foods Corporation, dedicated to healthy food products. These subsidiaries were created to streamline operations and enhance market reach. Additionally, the company implemented a 1-for-3 reverse stock split in January 2026, aimed at improving its stock price and market perception.

Operationally, VitaNova reported a significant increase in its customer base, particularly in the United States and Hong Kong, which accounted for $2.68 million and $345,578 in revenues, respectively. The company’s total current assets rose to $2.43 million, bolstered by a cash increase to $1.60 million. However, accounts receivable decreased to $726,743, indicating a potential challenge in cash flow management. The company also reported a total of seven full-time employees, with plans to expand its workforce in response to business growth.

Despite the revenue growth, the company faced challenges with rising costs, particularly in the cost of revenue, which surged by 95% to $2.11 million. This increase was largely due to the costs associated with the new food product line. Operating expenses also rose significantly, from $367,396 to $906,988, driven by higher legal and professional fees. The company’s management has acknowledged the need for improved internal controls and plans to address material weaknesses in its financial reporting processes.

Looking ahead, VitaNova aims to leverage its dual-brand strategy to enhance market penetration and customer engagement. The company is focused on expanding its product offerings and improving operational efficiencies while navigating the competitive landscape of the dietary supplement and healthy food markets. Management remains optimistic about future growth opportunities, particularly in the e-commerce space, as it continues to adapt to changing consumer preferences and market conditions.